Positives

• One Long COVID patient described feeling "alive and living again" during months 11-13 of their illness after using leronlimab, though the relief was temporary Reddit.
  
  
• In an ME/CFS-focused discussion, slightly over half of 40 patients treated with leronlimab were reported to have a "positive response," with effects lasting years for some Reddit.
  
  

Negatives

• Long COVID patients in CytoDyn's small Phase 2 leronlimab cohort reported no meaningful change in sore throat, exertional malaise, anxiety, nausea, or vomiting, while diarrhea was actually worse on leronlimab than placebo PMC.
• Access has been very limited for Long COVID patients: CytoDyn's expanded-access program has been reserved for triple-negative breast cancer, leaving long-haulers without a route to obtain the drug outside of closed clinical trials CytoDyn.

Hurdles & Side Effects

• Access is the main barrier — patients describe long waits and limited availability, with some still feeling stuck years into their illness while hoping to re-try treatments like leronlimab Reddit.